68Ga–Prostate-Specific Membrane Antigen PET/CT in Ovarian Tumors

Abstract

Purpose of the Report: Ovarian cancer is usually diagnosed in an advanced stage of disease due to the absence of specific symptoms and a lack of sensitive diagnostic methods. Prostate-specific membrane antigen (PSMA) is expressed on prostate cancer cells but can be found in other tumors such as ovarian cancer.The aim of this pilot study was to evaluate the feasibility of using 68 Ga-PSMA-11 PET/CT in detection of ovarian neoplasm before surgical treatment. Patients and Methods: Eight women with mean age of 56.0 ± 16.2 years were included in the study. All patients underwent transvaginal ultrasound followed by CT scan of the chest and abdomen as qualification for surgery. Within a 1-week interval, PET/CT was performed on a Siemens Biograph scanner, 60 minutes after injection of 2 MBq/kg 68 Ga-PSMA-11. Results: In 3 cases (37.5%), the 68 Ga-PSMA-11 PET/CT was positive, whereas histological examination confirmed 2 serous ovarian cancer cases and 1 ovarian borderline tumor. The SUV max in the serous ovarian cancer was 8.7 and 4.1, and in the borderline ovarian tumor, it was 13.8. No correlation was found between antigen CA-125 level and 68 Ga-PSMA expression. Range of tumor SUV max was not correlated with stage of disease. The remaining 62.5% (5/8) were negative in 68 Ga-PSMA-11 PET/CT, and histopathology confirmed benign pelvic tumor. Conclusions:The initial experience supports the potential to use 68 Ga-PSMA-11 in ovarian cancer to differentiate malignant and benign tumors before surgery.This study was approved by the Ethical Committee of the Medical University of Warsaw (KB/2/A/2018).

68Ga–Prostate-Specific Membrane Antigen PET/CT in Imaging of Hemangiopericytoma

“…3 A prostate-specific antigen is also found on the vessels of many other cancers such as glioma, hepatocellular carcinoma, ovarian cancer, and others. [4][5][6][7] The finding of PSMA expression opens a potential way for therapy based on this ligand, not only in prostate cancer. [8][9][10] We present 2 cases with recurrent of HP grade III.…”

“…It is a mesenchymal neoplasm that derives from pericytes surrounding the capillaries 3. A prostate-specific antigen is also found on the vessels of many other cancers such as glioma, hepatocellular carcinoma, ovarian cancer, and others [4][5][6][7]. The finding of PSMA expression opens a potential way for therapy based on this ligand, not only in prostate cancer [8][9][10].…”